Guilin Sanjin Pharmaceutical Co.,Ltd.’s Net Profit Rose 41% in First Quarter of 2023

Guilin Sanjin Pharmaceutical Co.,Ltd. (桂林三金药业股份有限公司) (002275.SZ) reported a net profit of 169.2 million yuan in the first quarter of 2023, up 41% year-on-year.

Meanwhile, the company posted 715.9 million yuan in revenue, up 38.5% year-on-year.

At the end of the reporting period, it had 4.1 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 27.4%.